Clinical Trials Browser

Phase 1 × Solid Tumours × Doxorubicin × Clear all

NCT06815575 2025-12-17

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

Phase 1 Recruiting

Other solid neoplasm

Solid Tumours